LSD1-mediated epigenetic reprogramming drives CENPE expression and prostate cancer progression

Y Liang, M Ahmed, H Guo, F Soares, JT Hua, S Gao… - Cancer research, 2017 - AACR
Androgen receptor (AR) signaling is a key driver of prostate cancer, and androgen-
deprivation therapy (ADT) is a standard treatment for patients with advanced and metastatic …

[HTML][HTML] Multi-institutional analysis shows that low PCAT-14 expression associates with poor outcomes in prostate cancer

NM White, SG Zhao, J Zhang, EB Rozycki, HX Dang… - European urology, 2017 - Elsevier
Abstract Background Long noncoding RNAs (lncRNAs) are an emerging class of relatively
underexplored oncogenic molecules with biological and clinical significance. Current …